Characterization and functional evaluation of JS207, a novel bispecific antibody against human PD-1 and VEGFA
{{output}}
Introduction: Cancer immunotherapy has been revolutionized by targeting PD-1 to restore antitumor T-cell activity and blocking VEGF to attenuate immunosuppressive tumor angiogenesis. While combining PD-1 and VEGF inhibition has s... ...
